Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

S. Hong, Theodore; Y. Wo, Jennifer; Y. Yeap, Beow; Ben‐Josef, Edgar; McDonnell, Erin; S. Blaszkowsky, Lawrence; L. Kwak, Eunice; N. Allen, Jill; W. Clark, Jeffrey; Goyal, Lipika; E. Murphy, Janet; Javle, Milind; A. Wolfgang, John; C. Drapek, Lorraine; S. Arellano, Ronald; J. Mamon, Harvey; T. Mullen, John; S. Yoon, Sam; K. Tanabe, Kenneth; R. Ferrone, Cristina; P. Ryan, David; F. DeLaney, Thomas; H. Crane, Christopher; X. Zhu, Andrew

doi:10.1200/jco.2015.64.2710

Public

Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma

Published in Journal of Clinical Oncology • Dec 15, 2015

Authors:

Theodore S. Hong

Jennifer Y. Wo

Beow Y. Yeap

Abstract

PURPOSE: To evaluate the efficacy and safety of high-dose, hypofractionated proton beam therapy for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). MATERIALS AND METHODS: In this single-arm, phase II, multi-institutional study, 92 patients with biopsy-confirmed HCC or ICC, ...

Subject

Medicine

Hepatocellular carcinoma

Intrahepatic Cholangiocarcinoma

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!